Your browser doesn't support javascript.
Coronavirus disease 2019 (COVID-19): first indication of efficacy of Gene-Eden-VIR/Novirin in SARS-CoV-2 infection.
Polansky, Hanan; Lori, Gillad.
  • Polansky H; The Center for the Biology of Chronic Disease (CBCD), 616 Corporate Way, Suite 2-3665, Valley Cottage, NY 10989, USA. Electronic address: hpolansky@cbcd.net.
  • Lori G; The Center for the Biology of Chronic Disease (CBCD), 616 Corporate Way, Suite 2-3665, Valley Cottage, NY 10989, USA.
Int J Antimicrob Agents ; 55(6): 105971, 2020 Jun.
Article in English | MEDLINE | ID: covidwho-143399
Semantic information from SemMedBD (by NLM)
1. Gene-Eden-VIR TREATS Severe Acute Respiratory Syndrome
Subject
Gene-Eden-VIR
Predicate
TREATS
Object
Severe Acute Respiratory Syndrome
2. Gene-Eden-VIR TREATS Severe Acute Respiratory Syndrome
Subject
Gene-Eden-VIR
Predicate
TREATS
Object
Severe Acute Respiratory Syndrome

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pneumonia, Viral / Quercetin / Selenium / Plant Extracts / Coronavirus Infections / Betacoronavirus Limits: Humans Language: English Journal: Int J Antimicrob Agents Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pneumonia, Viral / Quercetin / Selenium / Plant Extracts / Coronavirus Infections / Betacoronavirus Limits: Humans Language: English Journal: Int J Antimicrob Agents Year: 2020 Document Type: Article